Cargando…
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106517/ http://dx.doi.org/10.1186/1532-429X-13-S1-P304 |
| _version_ | 1782204796920397824 |
|---|---|
| author | Pepe, Alessia Meloni, Antonella Rossi, Giuseppe Dell'Amico, Maria Chiara Prossomariti, Luciano D'Ascola, Domenico G Filosa, Aldo Pepe, Pasquale Positano, Vincenzo Ascioti, Claudio Capra, Marcello Lombardi, Massimo |
| author_facet | Pepe, Alessia Meloni, Antonella Rossi, Giuseppe Dell'Amico, Maria Chiara Prossomariti, Luciano D'Ascola, Domenico G Filosa, Aldo Pepe, Pasquale Positano, Vincenzo Ascioti, Claudio Capra, Marcello Lombardi, Massimo |
| author_sort | Pepe, Alessia |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3106517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31065172011-06-03 A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy Pepe, Alessia Meloni, Antonella Rossi, Giuseppe Dell'Amico, Maria Chiara Prossomariti, Luciano D'Ascola, Domenico G Filosa, Aldo Pepe, Pasquale Positano, Vincenzo Ascioti, Claudio Capra, Marcello Lombardi, Massimo J Cardiovasc Magn Reson Poster Presentation BioMed Central 2011-02-02 /pmc/articles/PMC3106517/ http://dx.doi.org/10.1186/1532-429X-13-S1-P304 Text en Copyright ©2011 Pepe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Pepe, Alessia Meloni, Antonella Rossi, Giuseppe Dell'Amico, Maria Chiara Prossomariti, Luciano D'Ascola, Domenico G Filosa, Aldo Pepe, Pasquale Positano, Vincenzo Ascioti, Claudio Capra, Marcello Lombardi, Massimo A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| title | A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| title_full | A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| title_fullStr | A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| title_full_unstemmed | A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| title_short | A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| title_sort | t2* mri prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106517/ http://dx.doi.org/10.1186/1532-429X-13-S1-P304 |
| work_keys_str_mv | AT pepealessia at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT meloniantonella at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT rossigiuseppe at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT dellamicomariachiara at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT prossomaritiluciano at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT dascoladomenicog at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT filosaaldo at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT pepepasquale at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT positanovincenzo at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT ascioticlaudio at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT capramarcello at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT lombardimassimo at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT pepealessia t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT meloniantonella t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT rossigiuseppe t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT dellamicomariachiara t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT prossomaritiluciano t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT dascoladomenicog t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT filosaaldo t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT pepepasquale t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT positanovincenzo t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT ascioticlaudio t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT capramarcello t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy AT lombardimassimo t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithsequentialdeferipronedesferrioxamineversusdeferipronanddesferrioxamineinmonotherapy |